Showing results (251-260 of 523) with videos related to

Sort By:
Pageof 53
Bulletin Du Cancer|December 10, 2013
Combination of paclitaxel and bevacizumab in heavily pre-treated non-small-cell lung cancer (NSCLC) patients: a case series study on 15 patientsSylvestre Le Moulec, Julien Hadoux, Eric Gontier, et al.
Expert Review of Molecular Diagnostics|November 14, 2015
The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancerKirsty Ross, Emma Pailler, Vincent Faugeroux, et al.
JTO Clinical and Research Reports|February 24, 2025
Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance MechanismsArianna Marinello, Claudia Parisi, Damien Vasseur, et al.
Lung Cancer (Amsterdam, Netherlands)|November 29, 2024
Validation of the Lung Immune Prognostic Index in patients with untreated advanced non-small cell lung cancer: Post hoc analysis of the IMpower 130, 131 and 150 trialsEdouard Auclin, Matthieu Roulleaux Dugage, Teresa Gorria, et al.
Critical Reviews in Oncology/Hematology|February 19, 2011
Cardiac side effects of molecular targeted therapies: towards a better dialogue between oncologists and cardiologistsStephane Ederhy, Hassan Izzedine, Christophe Massard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Impact of bioinformatic procedures in the development and translation of high-throughput molecular classifiers in oncologyCharles Ferté, Andrew D Trister, Erich Huang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2022
Continuation of Lorlatinib in ALK-Positive NSCLC Beyond Progressive DiseaseSai-Hong I Ou, Benjamin J Solomon, Alice T Shaw, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 25, 2023
The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual SymposiumNuria Viñolas, Laura Mezquita, Jesús Corral, et al.
Annals of Diagnostic Pathology|May 23, 2020
Non-small cell lung carcinomas with CTNNB1 (beta-catenin) mutations: A clinicopathological study of 26 casesVincent Thomas de Montpréville, Ludovic Lacroix, Etienne Rouleau, et al.
The Lancet. Oncology|September 19, 2017
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trialDavid Planchard, Egbert F Smit, Harry J M Groen, et al.
Pageof 53